{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=acarbose", "query": { "intervention": "acarbose" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=acarbose&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-06T20:17:50.477Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02685852", "title": "Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hyperinsulinemic Hypoglycemia" ], "interventions": [ { "name": "Exenatide", "type": "DRUG" }, { "name": "Acarbose", "type": "DRUG" }, { "name": "Exenatide Placebo", "type": "DRUG" }, { "name": "Acarbose Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 11, "start_date": "2016-02", "completion_date": "2019-07-22", "has_results": false, "last_update_posted_date": "2021-05-06", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02685852" }, { "nct_id": "NCT00223691", "title": "Treatment of Orthostatic Hypotension in Autonomic Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autonomic Failure", "Orthostatic Hypotension" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Acarbose", "type": "DRUG" }, { "name": "Pyridostigmine Bromide", "type": "DRUG" }, { "name": "Yohimbine", "type": "DRUG" }, { "name": "Midodrine HCl", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Modafinil", "type": "DRUG" }, { "name": "Octreotide", "type": "DRUG" }, { "name": "water intake", "type": "OTHER" }, { "name": "Diphenhydramine Hydrochloride", "type": "DRUG" }, { "name": "Ranitidine HCL", "type": "DRUG" }, { "name": "Tranylcypromine", "type": "DRUG" }, { "name": "Ergotamine/ Caffeine", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Pseudoephedrine", "type": "DRUG" }, { "name": "Methylphenidate", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxymetazoline 0.05% nasal solution", "type": "DRUG" }, { "name": "Bovril", "type": "DIETARY_SUPPLEMENT" }, { "name": "Acetazolamide", "type": "DRUG" }, { "name": "Rivastigmine tartrate", "type": "DRUG" }, { "name": "Carbidopa/levodopa", "type": "DRUG" }, { "name": "Inflatable abdominal binder", "type": "DEVICE" }, { "name": "inflatable abdominal binder (sham)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "DEVICE" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 389, "start_date": "2002-03", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00223691" }, { "nct_id": "NCT02865499", "title": "Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Aging" ], "interventions": [ { "name": "acarbose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center at San Antonio", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "70 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "70 Years to 95 Years" }, "enrollment_count": 8, "start_date": "2016-06", "completion_date": "2017-10", "has_results": true, "last_update_posted_date": "2019-03-14", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02865499" }, { "nct_id": "NCT01470937", "title": "Early Diabetes Intervention Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Acarbose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "25 Years to 80 Years" }, "enrollment_count": 219, "start_date": "1998-02", "completion_date": "2004-09", "has_results": false, "last_update_posted_date": "2011-11-11", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01470937" }, { "nct_id": "NCT05542849", "title": "The Efficacy and Tolerability of Acarbose in Healthy Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tolerance", "Side Effect", "Glucose Response" ], "interventions": [ { "name": "Acarbose Tablets 50mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AgelessRx", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 15, "start_date": "2022-08-10", "completion_date": "2022-10-05", "has_results": false, "last_update_posted_date": "2023-07-27", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05542849" }, { "nct_id": "NCT02072096", "title": "A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Glimepiride", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Pioglitazone", "type": "DRUG" }, { "name": "Acarbose", "type": "DRUG" }, { "name": "Linagliptin", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" }, { "name": "Liraglutide", "type": "DRUG" }, { "name": "Insulin Glargine", "type": "DRUG" }, { "name": "Exenatide once weekly (QW)", "type": "DRUG" }, { "name": "Exenatide twice daily (BID)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 192, "start_date": "2014-02", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2019-10-09", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 16, "location_summary": "Miami, Florida • New Port Richey, Florida • Orlando, Florida + 12 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "New Port Richey", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Athens", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02072096" }, { "nct_id": "NCT00846521", "title": "Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pediatric Obesity", "Insulin Resistance", "Impaired Glucose Tolerance", "Cardiovascular Disease" ], "interventions": [ { "name": "Acarbose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "12 Years to 25 Years" }, "enrollment_count": 23, "start_date": "2006-09", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2013-05-01", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00846521" }, { "nct_id": "NCT03492580", "title": "A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diabetes Mellitus, Type 2", "Cardiovascular Diseases" ], "interventions": [ { "name": "Canagliflozin", "type": "DRUG" }, { "name": "Empagliflozin", "type": "DRUG" }, { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Dipeptidyl Peptidase-4 (DPP-4) Inhibitors", "type": "DRUG" }, { "name": "Glucagon-like Peptide-1 (GLP-1) Agonist", "type": "DRUG" }, { "name": "Anti-hyperglycemic Agents (AHA)", "type": "DRUG" }, { "name": "Thiazolidinediones (TZD)", "type": "DRUG" }, { "name": "Sulfonylureas (SU)", "type": "DRUG" }, { "name": "Insulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 714582, "start_date": "2018-02-22", "completion_date": "2018-06-25", "has_results": false, "last_update_posted_date": "2025-06-25", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 1, "location_summary": "Titusville, New Jersey", "locations": [ { "city": "Titusville", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03492580" }, { "nct_id": "NCT04877366", "title": "Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dietary Supplement" ], "interventions": [ { "name": "Dietary Supplement: Sprinkled Format REDUCOSE.", "type": "DIETARY_SUPPLEMENT" }, { "name": "Reference control", "type": "OTHER" }, { "name": "Active comparator", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Société des Produits Nestlé (SPN)", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 30, "start_date": "2021-07-21", "completion_date": "2021-12-01", "has_results": false, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 1, "location_summary": "Tustin, California", "locations": [ { "city": "Tustin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04877366" }, { "nct_id": "NCT01839344", "title": "Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Quercetin", "type": "DIETARY_SUPPLEMENT" }, { "name": "Acarbose", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "DRUG" ], "sponsor": "Bastyr University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 19, "start_date": "2013-05", "completion_date": "2015-03", "has_results": false, "last_update_posted_date": "2015-03-18", "last_synced_at": "2026-09-06T20:17:50.477Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01839344" } ] }